Cargando…
Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
With the gradual increase in the COVID-19 mortality rate, there is an urgent need for an effective drug/vaccine. Several drugs like Remdesivir, Azithromycin, Favirapir, Ritonavir, Darunavir, etc., are put under evaluation in more than 300 clinical trials to treat COVID-19. On the other hand, several...
Autores principales: | Saha, Sovan, Halder, Anup Kumar, Bandyopadhyay, Soumyendu Sekhar, Chatterjee, Piyali, Nasipuri, Mita, Bose, Debdas, Basu, Subhadip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390099/ https://www.ncbi.nlm.nih.gov/pubmed/34455072 http://dx.doi.org/10.1016/j.ymeth.2021.08.007 |
Ejemplares similares
-
Computational modeling of human-nCoV protein-protein interaction network
por: Saha, Sovan, et al.
Publicado: (2022) -
Assessment of GO-Based Protein Interaction Affinities in the Large-Scale Human–Coronavirus Family Interactome
por: Bandyopadhyay, Soumyendu Sekhar, et al.
Publicado: (2023) -
ML-DTD: Machine Learning-Based Drug Target Discovery for the Potential Treatment of COVID-19
por: Saha, Sovan, et al.
Publicado: (2022) -
Detection of spreader nodes in human-SARS-CoV protein-protein interaction network
por: Saha, Sovan, et al.
Publicado: (2021) -
PFP-GO: Integrating protein sequence, domain and protein-protein interaction information for protein function prediction using ranked GO terms
por: Sengupta, Kaustav, et al.
Publicado: (2022)